ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,799Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 253

$1.93M Total Retail Price of All Prescriptions

Rank: 1 out of 253

1,041 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 1,041 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

78% of this provider’s 1,041 patients filled at least one prescription for a schedule three drug, compared to an average of 32%.

Risky Drugs to Seniors

2% of this provider’s 10,403 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 11%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $37 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 4.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 6,546 1,528 S3 10 1 1
TIZANIDINE HCL 1,355 65 10 2 19
LISINOPRIL 1,293 373 3 4
GABAPENTIN 1,257 278 4 10
LYRICA 1,043 168 10 5 22
OMEPRAZOLE 1,001 328 6 2
ZOLPIDEM TARTRATE 851 109 7 17
NEXIUM 842 191 8 20
LEVOTHYROXINE SODIUM 619 257 9 6
SIMVASTATIN 619 255 9 5
METFORMIN HCL 527 124 11 9
MELOXICAM 447 78 12 12
AMLODIPINE BESYLATE 417 170 13 7
CYCLOBENZAPRINE HCL 415 44 R 14 27
VIMPAT 405 68 15 77
CLONIDINE HCL 397 112 16 26
ENDOCET 387 38 S2 17 59
TRAZODONE HCL 384 90 18 32
AMLODIPINE BESYLATE-BENAZEPRIL 379 146 19 70
METHOCARBAMOL 378 45 R 20 33
HYDROCHLOROTHIAZIDE 359 134 21 11
FUROSEMIDE 346 170 22 8
AMITRIPTYLINE HCL 327 57 R 23 45
OXYCODONE HCL 323 34 S2 24 29
SERTRALINE HCL 290 100 25 42
POTASSIUM CHLORIDE 281 189 26 14
METOPROLOL SUCCINATE 280 145 27 39
ATENOLOL 277 129 28 28
CARVEDILOL 274 123 29 18
AZITHROMYCIN 268 68 30 15
CITALOPRAM HBR 259 44 31 41
ROPINIROLE HCL 255 78 32 76
PROAIR HFA 248 57 33 44
METOPROLOL TARTRATE 242 78 34 24
WARFARIN SODIUM 241 139 35 13
CRESTOR 237 74 36 48
VENTOLIN HFA 235 66 37 59
GLIMEPIRIDE 230 76 38 51
SINGULAIR 227 53 39 81
PRAVASTATIN SODIUM 227 46 39 21
CLOPIDOGREL 212 81 41 53
LIDODERM 212 60 41 103
BISOPROLOL-HYDROCHLOROTHIAZIDE 210 76 43 105
PAROXETINE HCL 205 64 44 89
BUSPIRONE HCL 184 38 45 115
ATORVASTATIN CALCIUM 183 72 46 25
CYMBALTA 183 24 46 61
FLUOXETINE HCL 183 29 46 72
PANTOPRAZOLE SODIUM 179 44 49 35
NIFEDICAL XL 177 61 50 119
MONTELUKAST SODIUM 175 37 51 96
DOXEPIN HCL 173 74 52 97
TRIAMTERENE-HCTZ 168 52 53 71
RANITIDINE HCL 159 59 54 47
SPIRIVA 155 55 55 62
VOLTAREN 155 53 55 126
PLAVIX 153 62 57 85
PHENYTOIN SODIUM EXTENDED 153 49 57 100
ENALAPRIL MALEATE 152 57 59 63
ADVAIR DISKUS 152 31 59 73
ALLOPURINOL 147 91 61 57
DIGOXIN 133 87 62 68
VENLAFAXINE HCL ER 128 0 63 136
LOVAZA 127 47 64 117
HYDROXYZINE PAMOATE 126 0 R 65 139
DICLOFENAC SODIUM 126 27 65 98
ESCITALOPRAM OXALATE 117 44 67 66
LANTUS 117 27 67 40
NIASPAN 115 46 69 148
SYMBICORT 114 36 70 150
INSULIN SYRINGE 113 18 71 120
TRAMADOL HCL 112 38 72 3
NIFEDIPINE ER 110 68 73 153
TOPIRAMATE 107 0 74 155
TAMSULOSIN HCL 106 77 75 58
PREMARIN 99 12 R 76 160
METHYLPREDNISOLONE 99 15 76 34
LOVASTATIN 96 40 78 78
NABUMETONE 95 0 79 161
OXYCODONE HCL-ACETAMINOPHEN 92 17 S2 80 124
GLIPIZIDE 92 38 80 50
TRICOR 92 46 80 164
ISOSORBIDE MONONITRATE ER 90 45 83 92
CELEBREX 88 25 84 167
CEPHALEXIN 81 20 85 104
COMBIVENT 80 0 86 177
METOCLOPRAMIDE HCL 79 30 87 101
LOSARTAN POTASSIUM 76 34 88 46
SUMATRIPTAN SUCCINATE 76 0 88 179
PRAMIPEXOLE DIHYDROCHLORIDE 76 45 88 132
NASONEX 75 25 91 180
FLUCONAZOLE 75 12 91 116
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 17 93 23
DOXYCYCLINE HYCLATE 72 22 94 79
ALENDRONATE SODIUM 70 26 95 89
DIOVAN HCT 70 37 95 185
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 19 97 30
PENICILLIN V POTASSIUM 66 0 97 191
NAPROXEN 64 23 99 66
RAMIPRIL 63 52 100 128
DIOVAN 63 40 100 82
CHLORZOXAZONE 62 0 R 102 195
DONEPEZIL HCL 62 51 102 31
AMOXICILLIN 61 16 104 74
BENAZEPRIL HCL 61 22 104 135
LEVEMIR 60 12 106 106
HYDROXYZINE HCL 58 0 R 107 141
BUPROPION HCL SR 58 25 107 201
XOPENEX HFA 55 0 109 205
FLUTICASONE PROPIONATE 55 14 109 51
PREDNISONE 54 24 111 16
PROPRANOLOL HCL 54 20 111 148
DIVALPROEX SODIUM 53 0 113 110
QUETIAPINE FUMARATE 52 15 114 54
POLYETHYLENE GLYCOL 3350 52 28 114 55
TERAZOSIN HCL 51 48 116 213
GLIPIZIDE ER 50 33 117 216
FLUOCINOLONE ACETONIDE 50 0 117 216
DILANTIN 50 27 117 216
DEXILANT 50 24 117 216
LEVEMIR FLEXPEN 50 0 117 216
AVODART 50 48 117 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.